The Global Market for Energy Based Ablation Devices is Forecast to Reach US$25.4 Billion by 2022

Improved Procedural Outcomes Continues to Drive Demand for Energy Based Ablation Devices, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Energy Based Ablation Devices market. The global market for Energy Based Ablation Devices is forecast to reach US$25.4 billion by 2022, driven by technological advancements, growing demand for affordable minimally invasive procedures, and increasing prevalence of diseases such as carcer and cardiovascular disorders.

Energy based ablation devices involve controlled application of energy on target tissue to achieve the desired alteration in tissues. The global market for energy based ablation devices is primarily driven by factors such as continued technological advancements and growing prevalence of various diseases such as cardiovascular disorders and cancers among others. These devices are used in various procedures including cardiology, orthopedics, ophthalmology, dermatology, oncology, urology, gynecology, and neurosurgery. Ablation devices are preferred by physicians for their superior ability to cut and seal within minimal time. Demand for the devices is further buoyed by increasing adoption of minimally invasive procedures led by factors such as faster recovery from surgery, and improved procedural outcomes. Led by its high growth potential, the market continues to remain attractive for new players. Demand for ablation devices is expected to gain from technological innovations such as High-Intensity Focused Ultrasound (HIFU), and image-guided procedures.

Cancer treatment represents a major application area wherein afflicted tissues or tumors are ablated using different types of energy. Radio Frequency ablation constitutes an important market segment. While RF ablation devices are widely used in surgical oncology, fastest growth is expected to emerge from cardiovascular disease treatment. Innovations such as multiple-needle electrode are helping enhance the accuracy of RF ablation, which faces intense competition from other novel ablation technologies such as ultrasound, cryoablation and microwave among others. Microwave ablation especially poses strong competition to RF due to more successful outcomes of treatments for cancer. Demand for cryotherapy is also on rise as the procedure offers similar efficacy relative to RF based treatments but with a better safety profile for patients. Cryoablation finds use in the treatment of cancers of the lungs, kidneys and the liver. High intensity focused ultrasound (HIFU) is an emerging medical technology generally guided by ultrasound or MRI system that offers real time imaging to enable effective treatment at the site.

As stated by the new market research report on Energy Based Ablation Devices, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market, with a CAGR of 12.2% over the analysis period, led by factors such as growing population and healthcare burden; rising incidence of cancer as a result of globalization of unhealthy lifestyles and food habits; acute need for minimally invasive surgical methods to treat solid cancers; developing healthcare infrastructure; and rise of medical tourism in low cost Asian countries which are rapidly emerging as global hubs for cancer research and treatment.

Major players in the market include AngioDynamics Inc., Abbott EP, AtriCure Inc., Biosense Webster, Inc., Boston Scientific Corporation, BIOLASE Inc., biolitec AG, Cardiogenesis Corporation, EDAP TMS S.A., Ethicon Endo-Surgery Inc., Halyard Health Inc., InSightec® Ltd., Integra LifeSciences Corporation Lumenis Ltd., , Medtronic Inc., Monteris Medical Inc., Olympus America Inc., PhotoMedex Inc., Photocure ASA, ProstaLund AB, Sichuan Jinjiang Electronic Science and Technology Co. Ltd., Stryker Corporation, Smith & Nephew Plc, Syneron & Candela, and Varian Medical Systems, among others.

The research report titled "Energy Based Ablation Devices: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of major growth drivers, challenges, trends, and strategic corporate developments of major companies worldwide. Market estimates and projections are provided in US$ for geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), and Rest of World. Energy Sources analyzed include Electrical energy based ablation devices, Light based ablation devices, Radiation based ablation devices, Radiofrequency based ablation devices, Ultrasound based ablation devices, and Other energy source ablation devices (Cryotherapy, Hydromechanical, Microwave, and Hydrothermal energy based ablation devices).

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.